Predicting central cervical lymph node metastasis in papillary thyroid carcinoma with Hashimoto’s thyroiditis: a practical nomogram based on retrospective study
PeerJ · 2024
DOI: 10.7717/peerj.17108 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2024. Verfasst von Lirong Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, the Second Affiliated Hospital of Xi 'an Jiaotong University, Xi 'an, Shannxi, China. Hauptthemen laut MEDLINE: Hashimoto Disease, Nomograms, Lymphatic Metastasis, Thyroid Cancer, Papillary. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key R&D Program of Shaanxi Province.
Abstract (Originalsprache)
Background
In papillary thyroid carcinoma (PTC) patients with Hashimoto’s thyroiditis (HT), preoperative ultrasonography frequently reveals the presence of enlarged lymph nodes in the central neck region. These nodes pose a diagnostic challenge due to their potential resemblance to metastatic lymph nodes, thereby impacting the surgical decision-making process for clinicians in terms of determining the appropriate surgical extent.
Methods
Logistic regression analysis was conducted to identify independent risk factors associated with central lymph node metastasis (CLNM) in PTC patients with HT. Then a prediction model was developed and visualized using a nomogram. The stability of the model was assessed using ten-fold cross-validation. The performance of the model was further evaluated through the use of ROC curve, calibration curve, and decision curve analysis.
Results
A total of 376 HT PTC patients were included in this study, comprising 162 patients with CLNM and 214 patients without CLNM. The results of the multivariate logistic regression analysis revealed that age, Tg-Ab level, tumor size, punctate echogenic foci, and blood flow grade were identified as independent risk factors associated with the development of CLNM in HT PTC. The area under the curve (AUC) of this model was 0.76 (95% CI [0.71–0.80]). The sensitivity, specificity, accuracy, and positive predictive value of the model were determined to be 88%, 51%, 67%, and 57%, respectively.
Conclusions
The proposed clinic-ultrasound-based nomogram in this study demonstrated a favorable performance in predicting CLNM in HT PTCs. This predictive tool has the potential to assist clinicians in making well-informed decisions regarding the appropriate extent of surgical intervention for patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ultrasound, the Second Affiliated Hospital of Xi 'an Jiaotong University, Xi 'an, Shannxi, China.
- Department of Otolaryngology-Head and Neck Surgery, the Second Affiliated Hospital of Xi 'an Jiaotong University, Xi 'an, Shannxi, China.
- Department of Pathology, the Second Affiliated Hospital of Xi 'an Jiaotong University, Xi 'an, Shannxi, China.
Förderung
- National Natural Science Foundation of China
- Key R&D Program of Shaanxi Province
Zitieren
APA
Wang, L., Zhang, L., Wang, D., Chen, J., Su, W., Sun, L., Jiang, J., Wang, J., & Zhou, Q. (2024). Predicting central cervical lymph node metastasis in papillary thyroid carcinoma with Hashimoto’s thyroiditis: a practical nomogram based on retrospective study. PeerJ. https://doi.org/10.7717/peerj.17108
Vancouver
Wang L, Zhang L, Wang D, Chen J, Su W, Sun L, et al. Predicting central cervical lymph node metastasis in papillary thyroid carcinoma with Hashimoto’s thyroiditis: a practical nomogram based on retrospective study. PeerJ. 2024. doi:10.7717/peerj.17108
BibTeX
@article{Wang2024,
author = {Wang, Lirong and Zhang, Lin and Wang, Dan and Chen, Jiawen and Su, Wenxiu and Sun, Lei and Jiang, Jue and Wang, Juan and Zhou, Qi},
title = {Predicting central cervical lymph node metastasis in papillary thyroid carcinoma with Hashimoto’s thyroiditis: a practical nomogram based on retrospective study},
journal = {PeerJ},
year = {2024},
doi = {10.7717/peerj.17108}
}
EUVIMED